Shelley S. Magill, MD, PhD; Michael Klompas, MD, MPH; Robert Balk, MD; Suzanne M. Burns, RN, ACNP, MSN, RRT; Clifford S. Deutschman, MS, MD; Daniel Diekema, MD; Scott Fridkin, MD; Linda Greene, RN, MPS; Alice Guh, MD, MPH; David Gutterman, MD; Beth Hammer, RN, MSN, ANP-BC; David Henderson, MD; Dean R. Hess, PhD, RRT; Nicholas S. Hill, MD; Teresa Horan, MPH; Marin Kollef, MD; Mitchell Levy, MD; Edward Septimus, MD; Carole VanAntwerpen, RN, BSN; Don Wright, MD, MPH; Pamela Lipsett, MD, MHPE CHEST Nov, 2013;144(5):1448-1452
This article is an executive summary of a report from the Centers for Disease Control and Prevention Ventilator-Associated Pneumonia Surveillance Definition Working Group, entitled “Developing a new, national approach to surveillance for ventilator-associated events” and published in Critical Care Medicine (Magill SS, Klompas M, Balk R, et al. Developing a new, national approach to surveillance for ventilator-associated events. Crit Care Med. 2013;41(11):2467-2475.). The full report provides a comprehensive description of the Working Group process and outcome.
Weblink here